导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.73% | 2008/4773 |
| 近一周 | -0.06% | 903/5465 |
| 近一月 | 4.93% | 84/5421 |
| 近一季 | 5.70% | 298/5231 |
| 近半年 | 4.95% | 832/4920 |
| 近一年 | 3.58% | 2043/4394 |
| 近两年 | 37.61% | 2000/2954 |
| 近三年 | 46.10% | 639/2253 |
| 成立以来 | 42.19% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.81% 2922/4961 |
-8.09% 3834/5312 |
- - |
- - |
| 2025 | 9.95% 2842/4813 |
2.45% 1368/3635 |
11.26% 196/4076 |
-8.58% 4053/4524 |
5.51% 435/4813 |
| 2024 | 38.76% 33/3463 |
9.97% 92/2808 |
6.87% 117/3014 |
12.24% 2388/3129 |
5.19% 626/3463 |
| 2023 | -2.69% 599/2656 |
-2.60% 2024/2280 |
2.01% 182/2385 |
4.69% 136/2515 |
-6.45% 1779/2655 |
| 2022 | -4.75% 105/2207 |
1.99% 86/1919 |
-1.34% 1712/2016 |
-8.21% 179/2113 |
3.12% 767/2208 |
| 2021 | -1.18% 787/1822 |
10.15% 46/1255 |
-2.58% 1216/1330 |
-7.23% 1036/1466 |
-0.73% 1272/1822 |
| 2020 | -1.35% 953/1250 |
-14.20% 951/1028 |
1.77% 987/1067 |
3.86% 965/1164 |
8.78% 660/1184 |
| 2019 | - - |
- - |
- - |
-1.28% 641/850 |
6.10% 655/918 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 汇添富中证银行ETF联接C VS. 长安沪深300非周期A(740101) |